Mechanisms of thrombosis in cancer

Thrombosis Research

Volumn 131, Issue SUPPL.1, 2013, Pages

  Falanga, Anna ^a   Russo, Laura ^a   Verzeroli, Cristina ^a  

^a OSPEDALI RIUNITI   (Italy)

Author keywords

Hypercoagulability; Microparticles; Tissue factor; Tumor; Venous thromboembolism

Indexed keywords

ANASTROZOLE; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; BEVACIZUMAB; BIOLOGICAL MARKER; LENALIDOMIDE; THALIDOMIDE;

ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; CARDIOVASCULAR RISK; COLON CANCER; DEEP VEIN THROMBOSIS; HUMAN; HYPERCOAGULABILITY; LUNG NON SMALL CELL CANCER; MULTIPLE MYELOMA; NEOPLASM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK ASSESSMENT; SOLID TUMOR; THROMBOSIS; TUMOR GROWTH; VENOUS THROMBOEMBOLISM;

BLOOD COAGULATION; CELL ADHESION; DISEASE PROGRESSION; HEMOSTASIS; HUMANS; INFLAMMATION; NEOPLASMS; RISK ASSESSMENT; RISK FACTORS; THROMBOSIS;

EID: 84875164566     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/S0049-3848(13)70024-0     Document Type: Article

References (34)

1. AY Lee, MN Levine Venous thromboembolism and cancer: risks and outcomes Circulation 107 23 Suppl 1 2003 I17 I21
2. AA Khorana et al. Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients Cancer 110 10 2007 2339 2346
3. G Agnelli et al. A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project Ann Surg 243 1 2006 89 95
4. FR Rickles, A Falanga Molecular basis for the relationship between thrombosis and cancer Thromb Res 102 6 2001 V215 V224
5. A Falanga et al. Preliminary study to identify cancer patients at high risk of venous thrombosis following major surgery Br J Haematol 85 4 1993 745 750
6. AA Khorana et al. Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study Cancer 104 12 2005 2822 2829
7. C Ay et al. High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS) Blood 112 7 2008 2703 2708
8. C Ay et al. D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study J Clin Oncol 27 25 2009 4124 4129
9. A Falanga, CJ Tartari, M Marchetti Microparticles in tumor progression Thromb Res 129 Suppl 1 2012 S132 S136
10. JI Zwicker et al. Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy Clin Cancer Res 15 22 2009 6830 6840
11. JA Heit et al. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study Arch Intern Med 160 6 2000 809 815
12. T Wun, RH White Epidemiology of cancer-related venous thromboembolism Best Pract Res Clin Haematol 22 1 2009 9 23
13. AA Khorana et al. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy J Thromb Haemost 5 3 2007 632 634
14. SR Deitcher, MP Gomes The risk of venous thromboembolic disease associated with adjuvant hormone therapy for breast carcinoma: a systematic review Cancer 101 3 2004 439 449
15. M Baum et al. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial Lancet 359 9324 2002 2131 2139
16. CL Bennett et al. Thalidomide- and lenalidomide-associated thromboembolism among patients with cancer JAMA 296 21 2006 2558 2560
17. SR Nalluri et al. Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis JAMA 300 19 2008 2277 2285
18. CL Bennett et al. Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia JAMA 299 8 2008 914 924
19. AA Khorana et al. Development and validation of a predictive model for chemotherapy-associated thrombosis Blood 111 10 2008 4902 4907
20. C Ay et al. Prediction of venous thromboembolism in cancer patients Blood 116 24 2010 5377 5382
21. A Falanga, M Panova-Noeva, L Russo Procoagulant mechanisms in tumour cells Best Pract Res Clin Haematol 22 1 2009 49 60
22. A Falanga, SG Gordon Isolation and characterization of cancer procoagulant: a cysteine proteinase from malignant tissue Biochemistry 24 20 1985 5558 5567
23. MB Donati et al. Cancer procoagulant in human tumor cells: evidence from melanoma patients Cancer Res 46 12 Pt 1 1986 6471 6474
24. W Mielicki et al. Procoagulant activity of human stomach and colon cancers Oncology 47 4 1990 299 302
25. ME Tesselaar et al. Microparticle-associated tissue factor activity: a link between cancer and thrombosis? J Thromb Haemost 5 3 2007 520 527
26. I Del Conde et al. Microvesicle-associated tissue factor and Trousseau's syndrome J Thromb Haemost 5 1 2007 70 74
27. B Hugel et al. Membrane microparticles: two sides of the coin Physiology (Bethesda) 20 2005 22 27
28. G Hron et al. Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer Thromb Haemost 97 1 2007 119 123
29. N Magnus, D Garnier, J Rak Oncogenic epidermal growth factor receptor upregulates multiple elements of the tissue factor signaling pathway in human glioma cells Blood 116 5 2010 815 818
30. H Uusitalo-Jarvinen et al. Role of protease activated receptor 1 and 2 signaling in hypoxia-induced angiogenesis Arterioscler Thromb Vasc Biol 27 6 2007 1456 1462
31. JS Palumbo et al. Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells Blood 105 1 2005 178 185
32. FR Rickles, S Patierno, PM Fernandez Tissue factor, thrombin, and cancer Chest 124 3 Suppl 2003 58S 68S
33. QD Wu et al. Human neutrophils facilitate tumor cell transendothelial migration Am J Physiol Cell Physiol 280 4 2001 C814 C822
34. L Borsig Selectins facilitate carcinoma metastasis and heparin can prevent them News Physiol Sci 19 2004 16 21